These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4227190)

  • 21. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization against spontaneous and autografted mouse mammary carcinomas in the autochthonous C3H-Crgl mouse.
    Vaage J; Weiss DW
    Cancer Res; 1969 Nov; 29(11):1920-6. PubMed ID: 5358209
    [No Abstract]   [Full Text] [Related]  

  • 23. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
    Egawa K; Kiyohara T; Tanino T
    Jpn J Exp Med; 1982 Oct; 52(5):255-60. PubMed ID: 7169670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract]   [Full Text] [Related]  

  • 27. The nature of the anticoagulated host's immune response to the presence of an implanted spontaneous C3H/HeJ mouse mammary tumor.
    Liter M; Knapp K; Avila J; Costo M; Eckstrand B; Fan P; Kumasaka D; Matsuura G; Namba M; Romeo D
    Proc West Pharmacol Soc; 1985; 28():229-35. PubMed ID: 4070253
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrophage production by the bone marrow of tumor-bearing mice.
    Baum M; Fisher B
    Cancer Res; 1972 Dec; 32(12):2813-7. PubMed ID: 4644210
    [No Abstract]   [Full Text] [Related]  

  • 29. B7-1 and interleukin 12 synergistically induce effective antitumor immunity.
    Coughlin CM; Wysocka M; Kurzawa HL; Lee WM; Trinchieri G; Eck SL
    Cancer Res; 1995 Nov; 55(21):4980-7. PubMed ID: 7585539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro studies on the inhibitory effect of lymph-node cells. I. Antitumor activity of regional lymph-node cells from methylcholanthrene-induced sarcoma bearing mice on the same primary culture sarcoma cells.
    Osugi M
    Acta Med Okayama (1952); 1970 Aug; 24(4):447-56. PubMed ID: 4254199
    [No Abstract]   [Full Text] [Related]  

  • 31. Electron microscope study of antigens in cells of mouse mammary tumor cell lines by peroxidase-labeled antibodies in sera of mammary tumor-bearing mice and of patients with breast cancer.
    Hoshino M; Dmochowski L
    Cancer Res; 1973 Nov; 33(11):2551-61. PubMed ID: 4355972
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection against mammary tumors in mice by immunization with purified mammary tumor virus preparations.
    Burton DS; Blair PB; Weiss DW
    Cancer Res; 1969 Apr; 29(4):971-3. PubMed ID: 4304735
    [No Abstract]   [Full Text] [Related]  

  • 33. Mammary tumor virus activity in blood and mammary tissues of C3H and BALB/cf. C3H strains of mice.
    Nandi S; DeOme KB; Handin M
    J Natl Cancer Inst; 1965 Aug; 35(2):309-18. PubMed ID: 4283961
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of the mammary tumor virus in the immunogenicity of spontaneous mammary carcinomas of BALB/c mice and in the responsiveness of the hosts.
    Dezfulian M; Zee T; DeOme KB; Blair PB; Weiss DW
    Cancer Res; 1968 Sep; 28(9):1759-72. PubMed ID: 4300220
    [No Abstract]   [Full Text] [Related]  

  • 35. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays.
    Blazar BA; Laing CA; Miller FR; Heppner GH
    J Natl Cancer Inst; 1980 Aug; 65(2):405-10. PubMed ID: 6931258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunology of spontaneous mammary carcinomas in mice. 3. Immunogenicity of C3H preneoplastic hyperplastic alveolar nodules in C3Hf hosts.
    Lavrin DH; Blair PB; Weiss DW
    Cancer Res; 1966 Feb; 26(2):293-304. PubMed ID: 5903180
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system].
    Iunker VM; Arkhipov SA; Gruntenko EV
    Biull Eksp Biol Med; 1984 Nov; 98(11):598-600. PubMed ID: 6509179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MA891--an established spontaneous mouse mammary adenocarcinoma cell line and its immunologic characteristics].
    Zhou Y; Luo L; Liu X; Gao P; Su Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):273-7. PubMed ID: 10453566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.